An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
Scope of the Report:
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.
The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.
Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.
United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.
The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.
In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
The worldwide market for Infantile Spasms Therapeutics is expected to grow at a CAGR of roughly 3.0% over the next five years, will reach 150 million US$ in 2024, from 130 million US$ in 2019, according to a new WMR study.
This report focuses on the Infantile Spasms Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Injection
Market Segment by Applications, can be divided into
Hospital
Clinic
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Infantile Spasms Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Infantile Spasms Therapeutics, with price, sales, revenue and global market share of Infantile Spasms Therapeutics in 2017 and 2018.
Chapter 3, the Infantile Spasms Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infantile Spasms Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Infantile Spasms Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Infantile Spasms Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Infantile Spasms Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Injection
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mallinckrodt
2.1.1 Business Overview
2.1.2 Infantile Spasms Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Mallinckrodt Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 H. Lundbeck
2.2.1 Business Overview
2.2.2 Infantile Spasms Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 H. Lundbeck Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Insys Therapeutics
2.3.1 Business Overview
2.3.2 Infantile Spasms Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Insys Therapeutics Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Orphelia Pharma
2.4.1 Business Overview
2.4.2 Infantile Spasms Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Orphelia Pharma Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Valerion Therapeutics
2.5.1 Business Overview
2.5.2 Infantile Spasms Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Catalyst Pharmaceuticals
2.6.1 Business Overview
2.6.2 Infantile Spasms Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Anavex Life Sciences
2.7.1 Business Overview
2.7.2 Infantile Spasms Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Retrophin
2.8.1 Business Overview
2.8.2 Infantile Spasms Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Retrophin Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 GW Pharmaceuticals
2.9.1 Business Overview
2.9.2 Infantile Spasms Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Infantile Spasms Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Infantile Spasms Therapeutics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Infantile Spasms Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Infantile Spasms Therapeutics Manufacturer Market Share in 2018
3.3.2 Top 6 Infantile Spasms Therapeutics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Infantile Spasms Therapeutics Market Analysis by Regions
4.1 Global Infantile Spasms Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Infantile Spasms Therapeutics Sales and Market Share by Regions (2014-2019)
4.1.2 Global Infantile Spasms Therapeutics Revenue and Market Share by Regions (2014-2019)
4.2 North America Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
4.3 Europe Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
4.5 South America Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
5 North America Infantile Spasms Therapeutics by Country
5.1 North America Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
5.1.2 North America Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
5.2 United States Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
5.3 Canada Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
5.4 Mexico Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
6 Europe Infantile Spasms Therapeutics by Country
6.1 Europe Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
6.1.2 Europe Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
6.2 Germany Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
6.3 UK Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
6.4 France Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
6.5 Russia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
6.6 Italy Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
7 Asia-Pacific Infantile Spasms Therapeutics by Country
7.1 Asia-Pacific Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
7.2 China Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
7.3 Japan Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
7.4 Korea Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
7.5 India Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
8 South America Infantile Spasms Therapeutics by Country
8.1 South America Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
8.1.2 South America Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
8.2 Brazil Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
8.3 Argentina Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
8.4 Colombia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
9 Middle East and Africa Infantile Spasms Therapeutics by Countries
9.1 Middle East and Africa Infantile Spasms Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Infantile Spasms Therapeutics Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Infantile Spasms Therapeutics Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
9.3 Turkey Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
9.4 Egypt Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
9.5 Nigeria Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
9.6 South Africa Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
10 Global Infantile Spasms Therapeutics Market Segment by Type
10.1 Global Infantile Spasms Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Infantile Spasms Therapeutics Sales and Market Share by Type (2014-2019)
10.1.2 Global Infantile Spasms Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2014-2019)
10.2.2 Global Oral Price (2014-2019)
10.3 Injection Sales Growth and Price
10.3.1 Global Injection Sales Growth (2014-2019)
10.3.2 Global Injection Price (2014-2019)
11 Global Infantile Spasms Therapeutics Market Segment by Application
11.1 Global Infantile Spasms Therapeutics Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
12 Infantile Spasms Therapeutics Market Forecast (2019-2024)
12.1 Global Infantile Spasms Therapeutics Sales, Revenue and Growth Rate (2019-2024)
12.2 Infantile Spasms Therapeutics Market Forecast by Regions (2019-2024)
12.2.1 North America Infantile Spasms Therapeutics Market Forecast (2019-2024)
12.2.2 Europe Infantile Spasms Therapeutics Market Forecast (2019-2024)
12.2.3 Asia-Pacific Infantile Spasms Therapeutics Market Forecast (2019-2024)
12.2.4 South America Infantile Spasms Therapeutics Market Forecast (2019-2024)
12.2.5 Middle East and Africa Infantile Spasms Therapeutics Market Forecast (2019-2024)
12.3 Infantile Spasms Therapeutics Market Forecast by Type (2019-2024)
12.3.1 Global Infantile Spasms Therapeutics Sales Forecast by Type (2019-2024)
12.3.2 Global Infantile Spasms Therapeutics Market Share Forecast by Type (2019-2024)
12.4 Infantile Spasms Therapeutics Market Forecast by Application (2019-2024)
12.4.1 Global Infantile Spasms Therapeutics Sales Forecast by Application (2019-2024)
12.4.2 Global Infantile Spasms Therapeutics Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Infantile Spasms Therapeutics Picture
Table Product Specifications of Infantile Spasms Therapeutics
Figure Global Sales Market Share of Infantile Spasms Therapeutics by Types in 2018
Table Infantile Spasms Therapeutics Types for Major Manufacturers
Figure Oral Picture
Figure Injection Picture
Figure Infantile Spasms Therapeutics Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure United States Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure France Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure UK Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure China Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure India Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Infantile Spasms Therapeutics Revenue (Value) and Growth Rate (2014-2024)
Table Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table Mallinckrodt Infantile Spasms Therapeutics Type and Applications
Table Mallinckrodt Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table H. Lundbeck Infantile Spasms Therapeutics Type and Applications
Table H. Lundbeck Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Insys Therapeutics Basic Information, Manufacturing Base and Competitors
Table Insys Therapeutics Infantile Spasms Therapeutics Type and Applications
Table Insys Therapeutics Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Orphelia Pharma Basic Information, Manufacturing Base and Competitors
Table Orphelia Pharma Infantile Spasms Therapeutics Type and Applications
Table Orphelia Pharma Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Valerion Therapeutics Basic Information, Manufacturing Base and Competitors
Table Valerion Therapeutics Infantile Spasms Therapeutics Type and Applications
Table Valerion Therapeutics Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Catalyst Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Type and Applications
Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Anavex Life Sciences Basic Information, Manufacturing Base and Competitors
Table Anavex Life Sciences Infantile Spasms Therapeutics Type and Applications
Table Anavex Life Sciences Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Retrophin Basic Information, Manufacturing Base and Competitors
Table Retrophin Infantile Spasms Therapeutics Type and Applications
Table Retrophin Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GW Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table GW Pharmaceuticals Infantile Spasms Therapeutics Type and Applications
Table GW Pharmaceuticals Infantile Spasms Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Infantile Spasms Therapeutics Sales by Manufacturer (2017-2018)
Figure Global Infantile Spasms Therapeutics Sales Market Share by Manufacturer in 2017
Figure Global Infantile Spasms Therapeutics Sales Market Share by Manufacturer in 2018
Table Global Infantile Spasms Therapeutics Revenue by Manufacturer (2017-2018)
Figure Global Infantile Spasms Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Global Infantile Spasms Therapeutics Revenue Market Share by Manufacturer in 2018
Figure Top 3 Infantile Spasms Therapeutics Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Infantile Spasms Therapeutics Manufacturer (Revenue) Market Share in 2018
Figure Global Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Global Infantile Spasms Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Infantile Spasms Therapeutics Sales by Regions (2014-2019)
Table Global Infantile Spasms Therapeutics Sales Market Share by Regions (2014-2019)
Table Global Infantile Spasms Therapeutics Revenue by Regions (2014-2019)
Figure Global Infantile Spasms Therapeutics Revenue Market Share by Regions in 2014
Figure Global Infantile Spasms Therapeutics Revenue Market Share by Regions in 2018
Figure North America Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Europe Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure South America Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure North America Infantile Spasms Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Infantile Spasms Therapeutics Sales by Countries (2014-2019)
Table North America Infantile Spasms Therapeutics Sales Market Share by Countries (2014-2019)
Figure North America Infantile Spasms Therapeutics Sales Market Share by Countries in 2014
Figure North America Infantile Spasms Therapeutics Sales Market Share by Countries in 2018
Table North America Infantile Spasms Therapeutics Revenue by Countries (2014-2019)
Table North America Infantile Spasms Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Infantile Spasms Therapeutics Revenue Market Share by Countries in 2014
Figure North America Infantile Spasms Therapeutics Revenue Market Share by Countries in 2018
Figure United States Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Canada Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Mexico Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Europe Infantile Spasms Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Infantile Spasms Therapeutics Sales by Countries (2014-2019)
Table Europe Infantile Spasms Therapeutics Sales Market Share by Countries (2014-2019)
Table Europe Infantile Spasms Therapeutics Revenue by Countries (2014-2019)
Figure Europe Infantile Spasms Therapeutics Revenue Market Share by Countries in 2017
Figure Europe Infantile Spasms Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure UK Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure France Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Russia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Italy Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Infantile Spasms Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Infantile Spasms Therapeutics Sales by Countries (2014-2019)
Table Asia-Pacific Infantile Spasms Therapeutics Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Infantile Spasms Therapeutics Sales Market Share by Countries 2018
Table Asia-Pacific Infantile Spasms Therapeutics Revenue by Countries (2014-2019)
Figure Asia-Pacific Infantile Spasms Therapeutics Revenue Market Share by Countries 2018
Figure China Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Japan Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Korea Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure India Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Southeast Asia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure South America Infantile Spasms Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Infantile Spasms Therapeutics Sales by Countries (2014-2019)
Table South America Infantile Spasms Therapeutics Sales Market Share by Countries (2014-2019)
Figure South America Infantile Spasms Therapeutics Sales Market Share by Countries in 2018
Table South America Infantile Spasms Therapeutics Revenue by Countries (2014-2019)
Table South America Infantile Spasms Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Infantile Spasms Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Argentina Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Colombia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Infantile Spasms Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Infantile Spasms Therapeutics Sales by Countries (2014-2019)
Table Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Countries in 2018
Table Middle East and Africa Infantile Spasms Therapeutics Revenue by Countries (2014-2019)
Table Middle East and Africa Infantile Spasms Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Infantile Spasms Therapeutics Revenue Market Share by Countries in 2014
Figure Middle East and Africa Infantile Spasms Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure UAE Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Egypt Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure Nigeria Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Figure South Africa Infantile Spasms Therapeutics Sales and Growth Rate (2014-2019)
Table Global Infantile Spasms Therapeutics Sales by Type (2014-2019)
Table Global Infantile Spasms Therapeutics Sales Share by Type (2014-2019)
Table Global Infantile Spasms Therapeutics Revenue by Type (2014-2019)
Table Global Infantile Spasms Therapeutics Revenue Share by Type (2014-2019)
Figure Global Oral Sales Growth (2014-2019)
Figure Global Oral Price (2014-2019)
Figure Global Injection Sales Growth (2014-2019)
Figure Global Injection Price (2014-2019)
Table Global Infantile Spasms Therapeutics Sales by Application (2014-2019)
Table Global Infantile Spasms Therapeutics Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Infantile Spasms Therapeutics Sales, Revenue and Growth Rate (2019-2024)
Table Global Infantile Spasms Therapeutics Sales Forecast by Regions (2019-2024)
Table Global Infantile Spasms Therapeutics Market Share Forecast by Regions (2019-2024)
Figure North America Sales Infantile Spasms Therapeutics Market Forecast (2019-2024)
Figure Europe Sales Infantile Spasms Therapeutics Market Forecast (2019-2024)
Figure Asia-Pacific Sales Infantile Spasms Therapeutics Market Forecast (2019-2024)
Figure South America Sales Infantile Spasms Therapeutics Market Forecast (2019-2024)
Figure Middle East and Africa Sales Infantile Spasms Therapeutics Market Forecast (2019-2024)
Table Global Infantile Spasms Therapeutics Sales Forecast by Type (2019-2024)
Table Global Infantile Spasms Therapeutics Market Share Forecast by Type (2019-2024)
Table Global Infantile Spasms Therapeutics Sales Forecast by Application (2019-2024)
Table Global Infantile Spasms Therapeutics Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
Overview of the Global Advanced Therapeutics Pharmaceutical Outsourcing Market:
The report discusses everything a marketer requires before investing in the global Advanced Therapeutics Pharmaceutical Outsourcing Mar...
Overview of the Global Antibody Based Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Antibody Based Therapeutics Market during the forecast period 2023-2030. ...
Overview of the Global Office-Based Sleep Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Office-Based Sleep Therapeutics Market during the forecast period 202...
Overview of the Global Digital Therapeutics Navigation Platform Market:
The report discusses everything a marketer requires before investing in the global Digital Therapeutics Navigation Platform Market during the f...
Overview of the Global Substance Abuse Disorder Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Substance Abuse Disorder Therapeutics Market during the forecas...
Overview of the Global Patient-Specific Cancer Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Patient-Specific Cancer Therapeutics Market during the forecast ...
Description
The Nucleic Acid Based Therapeutics Market is poised for significant growth, with a projected expansion from USD 4.28 billion in 2022 to USD 9.51 billion by 2029, reflecting a robust compound annual growth rate (CAGR) of 11.6% during the forecast period of 2023-2029. This market pr...
Executive Summary
Azoth Analytics has released a research report titled "Global Branded PAH Therapeutics Market (2023 Edition)" which provides a complete analysis of the Global Branded PAH Therapeutics industry in terms of market segmentation By Drug Class (Endothelin Receptor Antagonis...
Overview of the Global Women's Healthcare Therapeutics Market:
The report discusses everything a marketer requires before investing in the global Women's Healthcare Therapeutics Market during the forecast period 202...
Overview of the Global Mrna Therapeutics Process Development Market:
The report discusses everything a marketer requires before investing in the global Mrna Therapeutics Process Development Market during the forecas...